ARCHIVES

FDA Expands Gleevec Indication For Children with Ph+ ALL

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

NCI’s Breast Cancer Screening Guidelines Released In Draft

September 24, 1993

Clinical Trials Approved By NCI Last Month Are Listed

February 28, 2003

DCBD Board Okays Concept Of Program Announcement To Stimulate Human Monoclonal Antibody Research

June 4, 1982

ESA Risk Mitigation Strategy Requires Training, Patient Consent, Documentation

February 19, 2010

Has To Plan International Meeting On Threat If DNA Biohazards

September 13, 1974

Cullen To Leave NCI, Will Become Director Of AMC Cancer Center; Nixon May Join ACS

April 14, 1989